| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection A Oliver, R Cantón, P Campo, F Baquero, J Blázquez Science 288 (5469), 1251-1253, 2000 | 1558 | 2000 |
| Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family ME Rad, P Bifani, C Martin, K Kremer, S Samper, J Rauzier, B Kreiswirth, ... Emerging infectious diseases 9 (7), 838, 2003 | 326 | 2003 |
| Antibiotic-selective environments F Baquero, MC Negri, MI Morosini, J Blázquez Clinical infectious diseases 27 (Supplement_1), S5-S11, 1998 | 281 | 1998 |
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants A Oliver, F Baquero, J Blázquez Molecular microbiology 43 (6), 1641-1650, 2002 | 266 | 2002 |
| β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity A Gutierrez, L Laureti, S Crussard, H Abida, A Rodriguez-Rojas, ... Nature communications 4 (1), 1-9, 2013 | 262 | 2013 |
| Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain A Aranaz, E Liébana, E Gómez-Mampaso, JC Galán, D Cousins, A Ortega, ... International Journal of Systematic and Evolutionary Microbiology 49 (3 …, 1999 | 241 | 1999 |
| Antibiotics and antibiotic resistance: a bitter fight against evolution A Rodríguez-Rojas, J Rodríguez-Beltrán, A Couce, J Blázquez International Journal of Medical Microbiology 303 (6-7), 293-297, 2013 | 235 | 2013 |
| β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver PLoS Pathog 5 (3), e1000353, 2009 | 232 | 2009 |
| Evolution of antibiotic resistance F Baquero, J Blázquez Trends in ecology & evolution 12 (12), 482-487, 1997 | 232 | 1997 |
| Hypermutation as a factor contributing to the acquisition of antimicrobial resistance GM Eliopoulos, J Blázquez Clinical Infectious Diseases 37 (9), 1201-1209, 2003 | 224 | 2003 |
| Victims of cardiac arrest occurring outside the hospital: a source of transplantable kidneys AI Sanchez-Fructuoso, M Marques, D Prats, J Conesa, N Calvo, ... Annals of internal medicine 145 (3), 157-164, 2006 | 188 | 2006 |
| Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection A Guerrero, J Cobo, J Fortün, E Navas, C Quereda, A Asensio, J Cañón, ... The Lancet 350 (9093), 1738-1742, 1997 | 183 | 1997 |
| Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. J Blazquez, MR Baquero, R Canton, I Alos, F Baquero Antimicrobial Agents and Chemotherapy 37 (10), 2059-2063, 1993 | 176 | 1993 |
| Structure-based enhancement of boronic acid-based inhibitors of AmpC β-lactamase GS Weston, J Blázquez, F Baquero, BK Shoichet Journal of medicinal chemistry 41 (23), 4577-4586, 1998 | 174 | 1998 |
| Antimicrobials as promoters of genetic variation J Blázquez, A Couce, J Rodríguez-Beltrán, A Rodríguez-Rojas Current opinion in microbiology 15 (5), 561-569, 2012 | 152 | 2012 |
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections A Oliver, BR Levin, C Juan, F Baquero, J Blázquez Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004 | 146 | 2004 |
| Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients JL Casado, MJ Perez-Elías, A Antela, R Sabido, P Martí-Belda, F Dronda, ... Aids 12 (11), F131-F135, 1998 | 138 | 1998 |
| Nanomolar inhibitors of AmpC β-lactamase F Morandi, E Caselli, S Morandi, PJ Focia, J Blázquez, BK Shoichet, ... Journal of the American Chemical Society 125 (3), 685-695, 2003 | 134 | 2003 |
| Antibiotic‐mediated recombination: ciprofloxacin stimulates SOS‐independent recombination of divergent sequences in Escherichia coli E López, M Elez, I Matic, J Blázquez Molecular microbiology 64 (1), 83-93, 2007 | 133 | 2007 |
| Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance A Castañeda-García, J Blázquez, A Rodríguez-Rojas Antibiotics 2 (2), 217-236, 2013 | 126 | 2013 |
Fernando BaqueroDpt. Microbiology IRYCIS, CIBERESP, Ramón y Cajal University Hospital, Madrid, SpainVerified email at bitmailer.net
